Saturday 17 October 2026
Export ANGO’s income statement to Excel — free account
AngioDynamics, Inc.
ANGO Healthcare Medical Instruments & Supplies
AngioDynamics, Inc.’s revenue for fiscal 2026 (year ended May 2026) was $320.2 million, up 9.46% from fiscal 2025. In the quarter to August 2026, revenue grew 6.87%, EPS grew 35.0% and free cash flow grew 5.62%, each against the same quarter a year earlier.
11.25
0.33
−2.85%
Follow ANGO
AngioDynamics, Inc. (ANGO) P/E ratio
AngioDynamics, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 245× (May 2018) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 0.0× | — |
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 11.5× | (75.71%) |
| FY2018 | 47.2× | (40.56%) |
| FY2017 | 79.4× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Aug 2026 | 0.0× | — |
| May 2026 | 0.0× | — |
| Feb 2026 | 0.0× | — |
| Nov 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
Low 0.0×
High 245×
Ten-year median
0.0×
Current reading's percentile
73
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| OSUR OraSure Technologies, Inc. compare | n/m |
| ANGO AngioDynamics, Inc. | n/m |
| AVR Anteris Technologies Global Corp. compare | n/m |
| SMTI Sanara MedTech Inc. compare | n/m |
| EMBC Embecta Corp. compare | 4.2× |
| UTMD Utah Medical Products, Inc. compare | 22.7× |
| STAA STAAR Surgical Company compare | 304× |
| NNNN Anbio Biotechnology compare | — |
| ZJYL Jin Medical International Ltd. compare | — |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)